ABOUT PALLEOS HEALTHCARE
palleos healthcare is a central European full-service Clinical Research Organization (CRO) focused on product development including pre-clinical consulting and clinical services for small to large scale trials. More than 10,000 patients in 300 sites have been treated throughout various indications.
The many years of experience of palleos healthcare makes it possible to provide customized services during the start-up phase, followed by consulting and project management during the preclinical and clinical research phase.
Through our cutting-edge project management and working with our established network of collaborators, we accelerate the journey towards overcoming public health challenges, today and tomorrow. With strong local expertise and focus on quality, palleos healthcare ensures seamless clinical trial conduct and drug registration, on time and within budget.
palleos healthcare provides a full range of high-quality CRO services for Phase I-IV, BE and RWE studies, with expertise in 29 therapeutic areas. From initial planning to study closure, we offer comprehensive expertise across all facets of clinical research ensuring precision and tailored solutions for every stakeholder involved.
Full-service clinical study engagements
- Clinical Study Design Preparation
- Medical Writing
- Consulting and Regulatory Support
- Project Management and Monitoring
- Drug Safety and Pharmacovigilance
- Data Management
- Biostatistics
- Clinical Supply Services and Logistics
- Marketing Authorization
- GMP Inspection Support
CONTACT INFORMATION
palleos healthcare
Taunusstrasse 5a
Wiesbaden, 65183
GERMANY
Phone: +49 611 950190 0
Fax: +49 611 950190 29
Contact: info@palleos.com
FEATURED ARTICLES
-
Explore this annual report that can assist decision-makers working to understand the clinical research market in Central and Eastern Europe.
-
Discover how a leading Indian pharmaceutical manufacturer and an Eastern European CRO successfully navigated the challenges of conducting clinical trials during the COVID-19 pandemic.
-
Patient enrollment is one of the biggest challenges for clinical trials in rheumatology. This article explains how to accelerate recruitment and ensure retention using digital solutions.
-
Gain insights from Kristina Bondareva, Head of Biostatistics at OCT Clinical, on the significance of the Addendum and the importance of adopting the estimand framework in clinical trials.
-
Check out the results from a clinical first-in-human study evaluating the safety and tolerability of an investigational cancer immunotherapy in patients with advanced melanoma.
-
COVID-19 impacted how clinical trials are conducted and emphasized the need to stay ahead of emerging viruses and diseases. Explore insights on which measures and approaches will most likely continue to be implemented in the future.
-
Gain insight into how a dermatology-specialized European CRO joined forces to carry out interim statistical analysis in its study on seven subjects and prepared necessary data packages for regulatory submission.
-
A leading Eastern European contract research organization completed the recruitment of 236 subjects in a Phase 3 osteoarthritis study for Handok Inc. despite hurdles caused by the COVID-19 pandemic.
-
Learn how database validation, database lock, and the development of the electronic CRF were used in a HER2-positive operable breast cancer study.
-
When your study is in trouble, choosing the right country can help get it back on track. While many countries can and should be considered, palleos healthcare discusses the countries they have experienced with regard to clinical trial rescue.